5-[5-(4-Methoxyphenyl)-3-naphthalen-2-yl-4,5-dihydropyrazol-1-yl]-3-morpholin-4-ylmethylthiazolidine-2,4-dione

ID: ALA2414934

PubChem CID: 72205239

Max Phase: Preclinical

Molecular Formula: C28H28N4O4S

Molecular Weight: 516.62

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  COc1ccc(C2CC(c3ccc4ccccc4c3)=NN2C2SC(=O)N(CN3CCOCC3)C2=O)cc1

Standard InChI:  InChI=1S/C28H28N4O4S/c1-35-23-10-8-20(9-11-23)25-17-24(22-7-6-19-4-2-3-5-21(19)16-22)29-32(25)27-26(33)31(28(34)37-27)18-30-12-14-36-15-13-30/h2-11,16,25,27H,12-15,17-18H2,1H3

Standard InChI Key:  FHQBRVCVSGSPFU-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 37 42  0  0  0  0  0  0  0  0999 V2000
   18.0011   -5.3617    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.1761   -5.3549    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.9127   -6.1368    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.5779   -6.6291    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.2470   -6.1480    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   19.0296   -6.4091    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.2747   -7.1963    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   20.0996   -7.2028    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.3615   -6.4196    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   19.6972   -5.9301    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.7028   -5.1052    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   20.5792   -7.8741    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   16.7748   -4.6340    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.2012   -3.9308    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.8007   -3.2104    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.9542   -4.6273    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.5513   -3.9099    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.9778   -3.1972    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.5739   -2.4738    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.7438   -2.4617    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.3192   -3.1791    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.7254   -3.8996    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.5723   -7.4541    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.8555   -7.8564    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.8495   -8.6806    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.5617   -9.0989    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.2814   -8.6869    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.2838   -7.8640    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.5570   -9.9239    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   16.8403  -10.3324    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.0740   -6.0036    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.7905   -6.4126    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   21.7903   -7.2348    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.5026   -7.6438    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.2175   -7.2313    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   23.2154   -6.4054    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.4985   -5.9919    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  1  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10  6  1  0
 10 11  2  0
  8 12  2  0
  2 13  1  0
 13 14  2  0
 14 15  1  0
 15 18  2  0
 17 16  2  0
 16 13  1  0
 17 18  1  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 17  1  0
  4 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 23  1  0
 26 29  1  0
 29 30  1  0
  9 31  1  0
 31 32  1  0
 32 33  1  0
 32 37  1  0
 33 34  1  0
 34 35  1  0
 35 36  1  0
 36 37  1  0
M  END

Associated Targets(Human)

OVCAR-4 (44535 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 516.62Molecular Weight (Monoisotopic): 516.1831AlogP: 4.31#Rotatable Bonds: 6
Polar Surface Area: 74.68Molecular Species: NEUTRALHBA: 8HBD:
#RO5 Violations: 1HBA (Lipinski): 8HBD (Lipinski): #RO5 Violations (Lipinski): 1
CX Acidic pKa: 13.11CX Basic pKa: 4.37CX LogP: 4.05CX LogD: 4.05
Aromatic Rings: 3Heavy Atoms: 37QED Weighted: 0.48Np Likeness Score: -1.13

References

1. Havrylyuk D, Zimenkovsky B, Vasylenko O, Day CW, Smee DF, Grellier P, Lesyk R..  (2013)  Synthesis and biological activity evaluation of 5-pyrazoline substituted 4-thiazolidinones.,  66  [PMID:23811085] [10.1016/j.ejmech.2013.05.044]

Source